We are live on ! Find out more
IMGN

Immunogen Inc
IMGN

Delisted

IMGN was delisted on the 9th of February, 2024.

Back to rankings

204 hedge funds and large institutions have $1B invested in Immunogen Inc in 2022 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 69 increasing their positions, 68 reducing their positions, and 44 closing their positions.

New
Increased
Maintained
Reduced
Closed

98% more call options, than puts

Call options by funds: $6.78M | Put options by funds: $3.42M

6% more capital invested

Capital invested by funds: $948M → $1B (+$55.2M)

1% more repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 68

8% less funds holding

Funds holding: 222 → 204 (-18)

39% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 44

Holders
204
Holders Change
-18
Holders Change %
-8.11%
% of All Funds
3.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
27
Increased
69
Reduced
68
Closed
44
Calls
$6.78M
Puts
$3.42M
Net Calls
+$3.35M
Net Calls Change
-$1.16M

Top Buyers

Rank Fund Capital Flow
1
WP
Woodline Partners
California
+$27.3M
2
MC
Maverick Capital
Texas
+$18M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$17.5M
4
Jennison Associates
Jennison Associates
New York
+$16M
5
State Street
State Street
Massachusetts
+$15.8M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$40M
2
ClearBridge Investments
ClearBridge Investments
New York
-$23.1M
3
Renaissance Technologies
Renaissance Technologies
New York
-$8.15M
4
Citadel Advisors
Citadel Advisors
Florida
-$7.67M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$6.76M
Name Holding Trade Value Shares
Change 		Change in
Stake
Federated Hermes
201
Federated Hermes
Pennsylvania
$45 +$22 +4 +80%
HNB
202
Huntington National Bank
Ohio
$5 – – –
ClearBridge Investments
203
ClearBridge Investments
New York
– -$23.1M -4,825,543 Closed
Renaissance Technologies
204
Renaissance Technologies
New York
– -$8.15M -1,705,140 Closed
MPAM
205
Monarch Partners Asset Management
Massachusetts
– -$3.23M -674,845 Closed
HF
206
HRT Financial
New York
– -$1.73M -361,353 Closed
ECM
207
ExodusPoint Capital Management
New York
– -$1.72M -360,717 Closed
Qube Research & Technologies (QRT)
208
Qube Research & Technologies (QRT)
United Kingdom
– -$1.6M -335,370 Closed
Ensign Peak Advisors
209
Ensign Peak Advisors
Utah
– -$1.44M -301,826 Closed
ACP
210
Acuta Capital Partners
California
– -$669K -140,000 Closed
SSA
211
Schonfeld Strategic Advisors
New York
– -$443K -92,603 Closed
Tudor Investment Corp
212
Tudor Investment Corp
Connecticut
– -$418K -87,428 Closed
PHK
213
Point72 Hong Kong
Hong Kong
– -$347K -72,610 Closed
HS
214
HighVista Strategies
Massachusetts
– -$311K -65,151 Closed
PL
215
Parkwood LLC
Ohio
– -$249K -52,000 Closed
DTL
216
Dynamic Technology Lab
Singapore
– -$247K -51,535 Closed
GC
217
Globeflex Capital
California
– -$227K -47,497 Closed
QT
218
Quantbot Technologies
New York
– -$213K -44,600 Closed
Envestnet Asset Management
219
Envestnet Asset Management
Illinois
– -$204K -42,726 Closed
Janney Montgomery Scott
220
Janney Montgomery Scott
Pennsylvania
– -$202K -42,326 Closed
NFC
221
Northeast Financial Consultants
Connecticut
– -$164K -34,315 Closed
GCM
222
Graham Capital Management
Connecticut
– -$153K -32,040 Closed
PI
223
PFS Investments
Georgia
– -$130 -27,156 Closed
ACM
224
Aquatic Capital Management
Illinois
– -$130K -27,100 Closed
VAS
225
Vestmark Advisory Solutions
Massachusetts
– -$119K -24,892 Closed
6 7 8
9
10

IMGN Hedge Fund Activity: Q4 2022 in Review

204 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q4 2022, worth a combined $1B — up 5.8% from $948M a quarter earlier.

Sellers outnumbered buyers: 44 funds closed out of IMGN and 27 opened new positions — a net loss of 17 holders — while 68 trimmed existing stakes and 69 added.

The largest buyer was Woodline Partners, opening a new position worth an estimated $27.3M. The largest seller was Deerfield Management, cutting an estimated $40M.

  • 204 institutional investors held Immunogen Inc (IMGN) as of Q4 2022, down from 222 in Q3 2022.
  • Funds reported $1B of Immunogen Inc stock for Q4 2022, up 5.8% quarter-over-quarter.
  • 27 funds opened new Immunogen Inc positions in Q4 2022 and 44 closed out, a net change of -17 holders.
  • The largest Immunogen Inc buyer in Q4 2022 was Woodline Partners, an estimated $27.3M added.
  • The largest Immunogen Inc seller in Q4 2022 was Deerfield Management, an estimated $40M sold.

Based on aggregated 13F filings for Q4 2022.